REFERENCES
- Awan M, Proudlock F A, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005; 46: 1435–1439, [PUBMED], [INFOTRIEVE], [CSA]
- Beck R W. The pediatric eye disease investigator group. J AAPOS 1998; 2: 255–256, [PUBMED], [INFOTRIEVE], [CSA]
- Clarke M P, Wright C M, Hrisos S, et al. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. Br Med J. 2003; 327: 1251–1256, [CSA]
- Cole S R, Beck R W, Moke P S, et al. The Amblyopia Treatment Index. J AAPOS 2001; 5: 250–254, [PUBMED], [INFOTRIEVE], [CSA]
- Holmes J M, Beck R W, Repka M X, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol. 2001; 119: 1345–1353, [PUBMED], [INFOTRIEVE], [CSA]
- Moseley M J, Neufeld M, Fielder A R. Treatment of amblyopia by spectacles. Ophthalmic Physiol Opt. 2002; 22: 296–299, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002; 120: 268–278, [CSA]
- Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. Am J Ophthalmol. 2003a; 136: 630–639, [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003b; 121: 603–611, [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003c; 121: 1625–1632, [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003d; 110: 2075–2087, [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004a; 8: 420–428, [CSA]
- Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004b; 111: 2076–2085, [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005a; 123: 149–157, [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005b; 123: 437–447, [CROSSREF], [CSA]
- Pediatric Eye Disease Investigator Group. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 2005c; 9: 129–136, [CSA]
- Stewart C E, Moseley M J, Fielder A R, Stephens D A, MOTAS Cooperative. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol. 2004a; 88: 1552–1556, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stewart C E, Moseley M J, Stephens D A, Fielder A R. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004b; 45: 3048–3054, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stewart C E, Fielder A R, Stephens D A, Moseley M J. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005a; 46: 3152–3160, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stewart C E, Moseley M J, Stephens D A, Fielder A R, ROTAS Cooperative. Modelling of treatment dose-response in amblyopia. Invest Ophthalmol Vis Sci. 2005b; 46, E-abstr. 3595[CROSSREF], [CSA]